- Home
- NXPL vs MDAI Comparison
NXPL vs MDAI Comparison
Compare NXPL & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- MDAI
- Stock Information
- Founded
- NXPL 1997
- MDAI 2013
- Country
- NXPL United States
- MDAI United States
- Employees
- NXPL N/A
- MDAI N/A
- Industry
- NXPL Telecommunications Equipment
- MDAI Medical/Dental Instruments
- Sector
- NXPL Telecommunications
- MDAI Health Care
- Exchange
- NXPL Nasdaq
- MDAI Nasdaq
- Market Cap
- NXPL 32.5M
- MDAI 28.3M
- IPO Year
- NXPL N/A
- MDAI N/A
- Fundamental
- Price
- NXPL $0.98
- MDAI $1.95
- Analyst Decision
- NXPL
- MDAI Strong Buy
- Analyst Count
- NXPL 0
- MDAI 2
- Target Price
- NXPL N/A
- MDAI $4.75
- AVG Volume (30 Days)
- NXPL 83.2K
- MDAI 616.5K
- Earning Date
- NXPL 04-10-2025
- MDAI 03-26-2025
- Dividend Yield
- NXPL N/A
- MDAI N/A
- EPS Growth
- NXPL N/A
- MDAI N/A
- EPS
- NXPL N/A
- MDAI N/A
- Revenue
- NXPL $66,482,000.00
- MDAI $27,264,000.00
- Revenue This Year
- NXPL N/A
- MDAI $61.78
- Revenue Next Year
- NXPL N/A
- MDAI N/A
- P/E Ratio
- NXPL N/A
- MDAI N/A
- Revenue Growth
- NXPL 179.89
- MDAI 44.52
- 52 Week Low
- NXPL $0.71
- MDAI $0.82
- 52 Week High
- NXPL $2.68
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- NXPL 43.52
- MDAI 45.75
- Support Level
- NXPL $0.96
- MDAI $1.86
- Resistance Level
- NXPL $1.12
- MDAI $2.25
- Average True Range (ATR)
- NXPL 0.09
- MDAI 0.15
- MACD
- NXPL -0.00
- MDAI -0.00
- Stochastic Oscillator
- NXPL 39.13
- MDAI 37.50
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.